Form 4: Hologic General Counsel Reports Stock Transactions

Hologic's General Counsel, Anne M. Liddy, reported recent stock transactions including RSU grants and tax-related share disposals.

Summary

• Anne M. Liddy, General Counsel of Hologic Inc. (HOLX), reported changes in her beneficial ownership of common stock.
• On November 7, 2025, 288 shares of common stock were disposed of at $74.1 per share to cover tax obligations in connection with the settlement of restricted stock units (RSUs).
• On November 10, 2025, 17,496 restricted stock units were acquired. These RSUs are scheduled to vest in equal installments on each of the first three anniversaries of the grant date.
• On November 11, 2025, an additional 406 shares of common stock were disposed of at $74.6 per share, also for tax obligations.
• Following these transactions, Ms. Liddy's beneficial ownership stands at 28,574 shares, which includes 346 shares acquired through the company's employee stock purchase plan since her last Form 4 filing.

Sentiment

Score: 6

Explanation: The filing indicates routine insider transactions, including a significant RSU grant which aligns management's interests with shareholders, offset by standard tax-related share disposals. No major positive or negative surprises are present.

Positives

• The acquisition of 17,496 restricted stock units demonstrates continued equity incentive for the General Counsel, aligning her long-term interests with those of shareholders.
• The transactions were made pursuant to a Rule 10b5-1(c) plan, indicating pre-planned and automated transactions designed to avoid insider trading concerns.

Negatives

• Disposal of a total of 694 shares (288 + 406) for tax obligations reduces direct beneficial ownership, although this is a common and expected practice upon RSU vesting.

Future Outlook

This Form 4 filing does not contain specific forward-looking statements or guidance regarding the company's future performance or outlook, beyond the vesting schedule of the granted restricted stock units.

Industry Context

This Form 4 filing details individual insider transactions and does not provide broader industry context or trends. The transactions reflect standard equity compensation practices within publicly traded companies.

Stakeholder Impact

• Shareholders: The grant of restricted stock units to the General Counsel aligns her long-term financial interests with the company's performance and shareholder value creation.
• Employees: The mention of shares acquired through the Employee Stock Purchase Plan (ESPP) indicates the company offers broad-based equity participation opportunities to its employees.

Next Steps

• The 17,496 restricted stock units acquired on November 10, 2025, will vest in equal installments on each of the first three anniversaries of the grant date.

Key Dates

Recommendation

This Form 4 filing details routine equity compensation and tax-related share disposals by a company executive. While the RSU grant aligns executive interests with shareholders, the transactions do not provide new fundamental information to warrant a change in investment recommendation. The stock price movements related to these transactions are typically minimal, suggesting a 'hold' position is appropriate based solely on this filing.

Keywords

Hologic, HOLX, Form 4, Insider Trading, Stock Transactions, Restricted Stock Units, RSU, Employee Stock Purchase Plan, ESPP, General Counsel, Anne M. Liddy, Equity Compensation